1. Medtronic’s Reveal LINQ Insertable Cardiac Monitor is inserted in the upper left side of the chest during a minimally invasive procedure and can monitor a patient’s heartbeat for up to three years.
2. Keytruda can now be used to treat patients with refractory classical Hodgkin lymphoma.
3. Kisqali is an oral drug that serves as a first-line treatment for post menopausal women with breast cancer when used in combination with letrozole, another type of breast cancer drug.
4. The Hospital Wearable Defibrillator is worn by patients at risk of ventricular tachycardia or ventricular fibrillation during their hospital stays to monitor for irregular heart rhythms.
5. Noctiva is a nasal spray intended to treat adults who frequently wake up at night to urinate.
6. The Vidas Brahms PCT Assay can now be used to help clinicians make antibiotic treatment decisions for patients with sepsis or lower respiratory tract infections.
More articles on supply chain:
Patients often skip, delay or ration cancer treatments due to high drug costs: 5 takeaways
7 things to know about Dr. Scott Gottlieb’s relationship with the drug industry
Mylan settles biosimilar patent dispute with Roche: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
